Epicast Report: Generalized Anxiety Disorder - Epidemiology Forecast to 2024 Key Trends, Size, Growth, Shares and Forecast

Submitted by: Submitted by

Views: 10

Words: 1035

Pages: 5

Category: Business and Industry

Date Submitted: 11/24/2015 11:13 PM

Report This Essay

Researchmoz added Most up-to-date research on "EpiCast Report: Generalized Anxiety Disorder - Epidemiology Forecast to 2024" to its huge collection of research reports.

GAD is a common mental illness that is characterized by persistent and unrelenting worrying about everyday things such as personal finances, health, family, and work. GAD can be accompanied by one or all of the following physical symptoms: headache, fatigue, restlessness, edginess, and increased irritability. GAD is only diagnosed if the patients worrying and anxiety present most days out of a week for at least six months in combination with one or more of the physical symptoms. The diagnosis of GAD must also be shown not to be directly related to any substance abuse disorder or general medical condition; it must not occur exclusively during an episodic mood disorder, psychotic disorder, or pervasive developmental disorder.

To Get Sample Copy of Report visit @ http://www.researchmoz.us/enquiry.php?type=S&repid=466522

GlobalData epidemiologists forecast that the 12-month total prevalent cases of GAD in the 8MM will grow by 4.8% from 13,688,954 cases in 2014 to 14,349,464 in 2024 and lifetime total prevalence will grow by 4.8% from 24,594,259 cases in 2014 to 25,770,599 in 2024. GlobalData epidemiologists predict that GAD will affect more women than men with 69.35% of 12-month GAD and 66.04% of lifetime GAD found in women in 2014. GlobalData epidemiologists forecast that the prevalence of 12-month and lifetime GAD peaks in the age group 5059 years, which contributed 23.57% of 12-month GAD and 23.54% of lifetime GAD in the 8MM in 2014.

GlobalDatas epidemiological analysis provides a country-specific forecast for the diagnosed prevalent cases of GAD in the 8MM during 20142024. GlobalDatas epidemiological forecast for the 12-month and lifetime total prevalent cases of GAD in the 8MM is supported by epidemiological data from country-specific studies, when available, which are nationally...